biologics manufacturing

biologics manufacturing

featured image of Powerhouse Partnership Forms Europe's Top Biologics CDMO

Powerhouse Partnership Forms Europe’s Top Biologics CDMO

BIOT

🔬💪 Biovian and 3P Biopharmaceuticals team up to form 3PBIOVIAN, a pan-European biologics CDMO with full development and manufacturing capabilities.

featured image of Game-Changing Merger Creates European CDMO Powerhouse

Game-Changing Merger Creates European CDMO Powerhouse

BIOT

🔍 Biovian and 3P Biopharmaceuticals merge to create 3PBIOVIAN, a European CDMO offering end-to-end services. 🌍👥🔬🧫🧬💪

featured image of Revolutionary Kyverna Cuts CAR-T Production to 3 Days

Revolutionary Kyverna Cuts CAR-T Production to 3 Days

BIOT

📰 CAR-T, a gamechanger in cancer treatment, could revolutionize patient access and save lives with Kyverna's 3-day process. 💉🔬

featured image of Boosting Manufacturing Efficiency: AI's Role in Cutting Costs and Enhancing Therapies

Boosting Manufacturing Efficiency: AI’s Role in Cutting Costs and Enhancing Therapies

BIOT

🧪 AI accelerates commercialization strategies by cutting costs and improving processes in advanced therapy manufacturing. 🔬 5 of batches fail, impacting health and revenues. 🧠 AI is crucial for complex therapies. 💰 Manufacturers need to optimize processes and reduce costs. 🌐 AI enables learning transfer and supports decision-making. 📈 Industry 4.0 will use machine learning for real-time predictions and support.

featured image of Sleep Tech Startup Onera Health Raises $32M in Funding

Sleep Tech Startup Onera Health Raises $32M in Funding

BIOT

📢 Sleep diagnostics specialist Onera Health raises €30m ($32m) in Series C round, accelerating manufacturing and expanding devices. 💤💰

featured image of Massive Growth in UK ADC Facility Boosts Biopharmaceutical Industry

Massive Growth in UK ADC Facility Boosts Biopharmaceutical Industry

BIOT

📰 CDMO Piramal bulks out UK ADC facility! 💊🧪 Enhanced capabilities to meet growing demand in biopharmaceutical industry. 🌍👥

featured image of Moderna's $900m Investment for Global Biotech Growth

Moderna’s $900m Investment for Global Biotech Growth

BIOT

💰 Moderna plans to invest $900m in capital expenditures in 2024 to support growth ambitions in biotechnology. 🔬🌍⚙️💉

featured image of Pharma's Tech Revolution: AI and Synbio Supercharge Biologics

Pharma’s Tech Revolution: AI and Synbio Supercharge Biologics

BIOT

📰 Pharma is using new technologies like AI and synthetic biology to maximize biologics manufacturing. 💊 Innovations are improving antibody stability and yield, accelerating production and drug development. 🌐

featured image of Breakthrough: New Cell Type for Better AAV-Based Drugs!

Breakthrough: New Cell Type for Better AAV-Based Drugs!

BIOT

🔬 Researchers are searching for the perfect cell type to produce rAAVs for gene therapies. 🧪 HEK293 and CHO cells are being considered. 🐹💡🌐

featured image of 2024: The Year of Breakthroughs in Bioprocessing?

2024: The Year of Breakthroughs in Bioprocessing?

BIOT

Will 2024 be the year of breakthroughs in bioprocessing? 🌟 Find out in this insightful article! Bioprocessing2024